Citi Pharma (KAR:CPHL) Forward Dividend Yield % : 8.72% (As of Jun. 08, 2024)

Competitive Comparison of Citi Pharma's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Citi Pharma's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Citi Pharma's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Citi Pharma's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Citi Pharma's Forward Dividend Yield % falls into.

Citi Pharma Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Citi Pharma Recent Full-Year* Dividend History

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Citi Pharma's Forward Annual Dividend Yield (%) for Today is calculated as

Current Share Price is ₨29.00.
Citi Pharma's Dividends per Share for the forward twelve months is calculated as ₨2.5 * 1 = ₨2.5.

Citi Pharma's Trailing Annual Dividend Yield (%) for Today is calculated as

Current Share Price is ₨29.00.
Citi Pharma's Dividends per Share for the trailing twelve months (TTM) ended in Today is ₨2.5.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Citi Pharma  (KAR:CPHL) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Citi Pharma Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Citi Pharma's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Citi Pharma (KAR:CPHL) Business Description